Pharmafile Logo

Event Logistics

Jacques Dumas joins Nosopharm scientific advisory board

French biotech's appointments also include Dominique Breilh

- PMLiVE

Charity coalition pledges millions for brain disease research

Will invest £30m developing candidates for neurodegenerative conditions

- PMLiVE

The impact of the US Sunshine Act

A new dawn begins for pharma’s payments to doctors in the US

- PMLiVE

Reckitt to spin-off pharma unit as Indivior

Demerged business will focus on opioid dependence product Suboxone

- PMLiVE

AZ says cancer will be ‘sixth growth platform’

Firm currently has 14 drugs in phase III trials

- PMLiVE

Merck’s ezetimibe has ‘modest’ benefit when added to statins

Combination showed a reduction in cardiovascular events in patients with ACS

- PMLiVE

Creston Health rebrands under Health Unlimited banner

Agencies including Red Door and PAN will operate separately and together

- PMLiVE

Actavis looks to PepsiCo for CFO

Maria Teresa Hilado will help guide company through Allergan aquisition

- PMLiVE

Actavis to buy Allergan for $66bn

Ends Valeant’s pursuit of Botox maker

- PMLiVE

EMA leaderless as tribunal forces Guido Rasi out

Court annuls appointment of executive director due to selection process concerns

- PMLiVE

Pfizer signs $2.85bn immuno-oncology alliance

Will jointly develop Merck KGaA's lead anti-PD-L1 drug

- PMLiVE

Life sciences minister: Go digital for NHS savings

Greater use of health technology could free funds for drug spending, says George Freeman

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links